DALLAS, June 23, 2020 – About 22% of people with heart disease struggle with depression[i] and according to a 2015 study published in the Journal of Clinical Psychiatry, depression alone costs the U.S. economy an estimated $210 billion per year, with more than 60% of the cost related to treating comorbid conditions such as diabetes and heart disease. To help people with heart disease make meaningful behavior change so they can live life more fully, the American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives, and Happify Health have worked together to incorporate the Association’s science-based health content into Happify Heart and Mind, a new mental health program offered through the Happify Health Solutions platform to employers and health plans.
Happify Heart and Mind teaches people with high blood pressure and high cholesterol strategies to reduce stress, incorporate more heart-healthy foods into their diet, and integrate more movement into their days. A variety of activities are available, including guided meditations, healthy meal prep strategies, psychoeducational content and goal-setting exercises. Happify Heart and Mind features a total of 10 content tracks, including the exclusive track developed by the Association, “Defeat Stress and Live a Heart-Healthy Life,” as well as many of Happify's specially curated tracks for a healthy lifestyle, such as “Get Motivated to Get Fit,” and “Your Anxiety Antidote: Mindfulness Meditation.” Also incorporated in the program are heart-healthy physical activities, including short videos that feature stretching, core exercises, resistance training, and mindful yoga flows.
“We are honored to be working with the American Heart Association to help meet the mental health needs of those living with cardiovascular disease–needs that have become more complicated during this global pandemic," said Ofer Leidner, president and co-founder at Happify Health, “We’re proud to offer Heart and Mind as a healthy resource that can be used anywhere and at any time, to help people with heart disease and stroke survivors better cope with their symptoms while at home, now, and in the future.”
Multiple studies[ii] recently presented at the American Heart Association’s Scientific Sessions reinforced the link between mental health and cardiovascular health. The correlation is also a focus of the Association’s 40-plus member CEO Roundtable leadership collaborative, which produced a roadmap for employers to tackle growing challenges for addressing mental health issues. The CEO Roundtable has also launched a nationwide public awareness campaign that aims to normalize the conversation around mental health, reduce stigma, and help employees engage with company-provided resources to address this prevalent health issue.
“With our increased focus on the links between mental health and cardiovascular disease and stroke, this collaboration with Happify is a natural extension of the Association’s increased focus on the links between mental health and cardiovascular disease,” said Eduardo Sanchez, M.D., chief medical officer for prevention at the American Heart Association. “As we work toward a world of longer, healthier lives, it’s important for us to address all of the risk factors that impact people’s health, from Life’s Simple 7 to mental health.”
Following the Association’s Life’s Simple 7, the seven risk factors that people can improve through lifestyle changes to help achieve ideal cardiovascular health, can greatly increase physical and mental wellness and decrease deaths by 76%. However, according to an AHA Journals published study, just 1% of people do all seven, and 91% do just one. A study published by the National Center for Biotechnology Information (NCBI) found that up to 40% of cardiac patients meet the criteria for major depressive disorder or experience an elevation in depressive symptoms.
The efficacy of Happify’s therapy has been proven through two randomized controlled trials and three published studies in peer-reviewed publications. One published randomized controlled trial found a 25% reduction in both the symptoms of anxiety and depression for those using Happify, when compared with an active comparison condition, psychoeducation, used as directed by this study. More information about Happify’s scientific testing and research science can be found on the Happify Labs page.
About the American Heart Association
The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies and share lifesaving resources and information. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
About Happify Health
Happify Health is a LifeTech company that delivers digital therapeutics and innovative care delivery models to improve mental and physical health. As a leader in digital therapeutic solutions, Happify Health’s safe, effective digital tools use scientific research from positive psychology, CBT and mindfulness, combined with a gamified approach and leading-edge technology, to impact everyday lives. Happify Health's clinically validated platform provides global access to one of the most comprehensive, evidence-based intervention catalog that is available from science, resulting in better health and business outcomes for organizations. For more information, visit happifyhealth.com.
For press inquiries, contact:
Britta Franson, Director PR and Communications, Happify Health | email@example.com
Tracie Bertaut: firstname.lastname@example.org, 504-722-1695
For Public Inquiries: (800) AHA-USA1 (242-8721)
[i] Mental Health: A workforce Crisis, American Heart Association, CEO Roundtable, 2019.
2019 ACC/AHA Guideline on Primary Prevention of Cardiovascular Disease
Lima, B., Hammadah, M., Pearce, B., Shah, A., Moazzami, K., Kim, J., Sullivan, S., Levantsevych, O., Young, A., Lewis, T., Elon, L., Raggi, P., Bremner, J., Quyyumi, A., Vaccarino, V., Posttraumatic Stress Disorder is Associated With Mental Stress-Induced Myocardial Ischemia in Men and Women After a Recent Myocardial Infarction, 11 Nov 2019 Circulation. 2019;140:A14796
Lopez, K., Gonzalez, V., Cutitta, K., Shabosky, J., Bilal, M., Kimbro, R., Depression, Anxiety, and Attention Deficit Hyperactivity Disorder in Youth With Cardiac Arrhythmias: A Cross Sectional Comparative Study, 11 Nov 2019, Circulation. 2019;140:A13753
Ebrahimi, R., Sumner, J., Lynch, K., Viernes, B., Coronado, G., Naeim, A., Tseng, C., Dennis, P., Beckham, J., Posttraumatic Stress Disorder & Prevalence of Cardiovascular Risk Factors Among Women Veterans, 11 Nov 2019, Circulation. 2019;140:A12586